PubRank

T Cabrera

Author PubWeight™ 34.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today 1997 2.89
2 Natural history of HLA expression during tumour development. Immunol Today 1993 2.04
3 Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J Infect Dis 2001 1.33
4 Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors. Tissue Antigens 2003 1.09
5 The HLA crossroad in tumor immunology. Hum Immunol 2000 1.06
6 HLA class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Res 1992 1.05
7 Comparison of oral health among older people with and without dementia. Community Dent Health 2014 1.01
8 Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors. Int J Cancer 1999 1.00
9 Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. Semin Cancer Biol 1991 0.99
10 Separation distress call in the human neonate in the absence of maternal body contact. Acta Paediatr 1995 0.95
11 Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides. Tissue Antigens 1998 0.95
12 Expression of HLA G in human tumors is not a frequent event. Int J Cancer 1999 0.93
13 Can the HLA phenotype be used as a prognostic factor in breast carcinomas? Int J Cancer Suppl 1991 0.90
14 Molecular strategies to define HLA haplotype loss in microdissected tumor cells. Hum Immunol 2000 0.90
15 Presence of HPV 16 sequences in laryngeal carcinomas. Int J Cancer 1990 0.89
16 Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness. Exp Clin Immunogenet 1987 0.89
17 HLA class I antigens in human tumors. Adv Cancer Res 1995 0.88
18 Lower body temperatures in infants delivered by caesarean section than in vaginally delivered infants. Acta Paediatr 1993 0.88
19 Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours. Tissue Antigens 2007 0.88
20 Complete response of hepatocellular carcinoma with sorafenib and Y radioembolization. Curr Oncol 2010 0.87
21 Heterogeneity of the expression of class I and II HLA antigens in human breast carcinoma. J Immunogenet 1987 0.86
22 Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon. Tissue Antigens 1996 0.85
23 Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma. Tissue Antigens 2006 0.85
24 Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma. Curr Oncol 2013 0.84
25 HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix. Tissue Antigens 1993 0.83
26 Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue. Tissue Antigens 2009 0.83
27 Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression. Cancer Immunol Immunother 2000 0.82
28 Successful salvage of kidney allografts threatened by ureteral stricture using pyelovesical bypass. Am J Transplant 2010 0.81
29 Molecular analysis of MHC-class-I alterations in human tumor cell lines. Int J Cancer Suppl 1991 0.81
30 MHC class I and II antigens on gastric carcinomas and autologous mucosa. J Immunogenet 1990 0.80
31 K-ras mutations (codon 12) are not involved in down-regulation of MHC class-I genes in colon carcinomas. Int J Cancer 1990 0.79
32 Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation. Cancer Res 1991 0.78
33 Class II HLA antigen expression in familial polyposis coli is related to the degree of dysplasia. Immunobiology 1990 0.77
34 A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*0301 allele in a prostate carcinoma cell line. Immunogenetics 2001 0.77
35 The biological consequences of altered MHC class I expression in tumours. J Biol Regul Homeost Agents 1999 0.77
36 Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast. Eur J Immunogenet 1995 0.76
37 [Epithelioid hemangioendothelioma: a rare hepatic tumor]. Rev Esp Enferm Dig 1995 0.75
38 [Expulsion of the fetus while standing]. Rev Enferm 1991 0.75
39 Looking for HLA-G expression in human tumours. J Reprod Immunol 1999 0.75
40 HLA class I and II expression in rhabdomyosarcomas. Immunobiology 1991 0.75
41 [The value of symptoms in the diagnosis of peptic ulcer: an approximation to the primary care medium]. Rev Esp Enferm Dig 1996 0.75
42 [The endoscopic management of postoperative biliary fistulae]. Rev Esp Enferm Dig 1994 0.75
43 A monoclonal antibody GR2110 reactive with a P24 antigen present in a subgroup of acute lymphoid leukemias. Hybridoma 1985 0.75
44 Characterization of monoclonal antibodies directed against HLA class II molecules. Hybridoma 1986 0.75
45 [Maternal-infant care in primary care]. Nueva Enferm 1981 0.75
46 Beta2-microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors. Int J Clin Lab Res 2000 0.75
47 Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine. NIDA Res Monogr 1989 0.75